Sort
15,273 grants matching “antimicrobial resistance”
Modulation of the gut microbiome to enhance efficacy of immunotherapy in pancreatic adenocarcinoma
$399,752Deepak Saxena · Periomics Care, Llc · R41 · FY2020 · CA
RFA-GH-23-003, THAI-GER: THAIland Genomic surveillance of Emerging infectious diseases facilitating Rapid response
$399,743Navin Horthongkham · Mahidol University · U01 · FY2023 · GH
Phase 2 Study of Intravenous Gallium Nitrate in the Treatment of Cystic Fibrosis
$399,680Christopher Hooper Goss · University Of Washington · R01 · FY2016 · FD
Integration of redox-balancing mechanisms in Pseudomonas aeruginosa biofilms
$399,648Lars Dietrich · Columbia Univ New York Morningside · R01 · FY2022 · AI
Integration of redox-balancing mechanisms in Pseudomonas aeruginosa biofilms
$399,648Lars Dietrich · Columbia Univ New York Morningside · R01 · FY2021 · AI
Integration of redox-balancing mechanisms in Pseudomonas aeruginosa biofilms
$399,648Lars Dietrich · Columbia Univ New York Morningside · R01 · FY2020 · AI
Integration of redox-balancing mechanisms in Pseudomonas aeruginosa biofilms
$399,648Lars Dietrich · Columbia Univ New York Morningside · R01 · FY2019 · AI
Molecular mechanisms of uropathogenesis
$399,610Harry L. Mobley · University Of Michigan At Ann Arbor · R01 · FY2016 · AI
Phase 2 Study of Intravenous Gallium Nitrate in the Treatment of Cystic Fibrosis
$399,524Christopher Hooper Goss · University Of Washington · R01 · FY2013 · FD
Forecasting Trachoma Control
$399,420Thomas M Lietman · University Of California, San Francisco · R01 · FY2016 · EY
Forecasting Trachoma Control
$399,420Thomas M Lietman · University Of California, San Francisco · R01 · FY2017 · EY
The Outer Surface of Vibrio Cholerae
$399,383Michael Stephen Trent · University Of Georgia · R01 · FY2015 · AI
HTS assays for the methylerythritol-4-phosphate pathway
$399,241Dean C Crick · Colorado State University · R01 · FY2012 · AI
Mechanisms of evolution at the host-pathogen interface
$399,227Matthew Frederick Barber · University Of Oregon · R35 · FY2025 · GM
Phase 2 Study of Intravenous Gallium Nitrate in the Treatment of Cystic Fibrosis
$399,209Christopher Hooper Goss · University Of Washington · R01 · FY2017 · FD
Toolbox for Tuberculosis Drug Development
$399,144William Ramses Bishai · Johns Hopkins University · R01 · FY2006 · AI
Rat, a regulator of autolysis in S. aureus
$399,137Dartmouth College · R01 · FY2005 · AI
Biologically Active Cyclic Peptides
$399,124Dale L Boger · Scripps Research Institute, The · R01 · FY2019 · CA
Metabolomics driven discovery of drug leads from symbiotic bacteria
$399,022David R Andes · University Of Wisconsin-Madison · U19 · FY2014 · AI
Mouse Infection Core
$399,008Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2015 · AI
Primary and Therapy-Resistant Endodontic Infections
$398,999University Of Maryland Baltimore · R01 · FY2005 · DE
Integration of redox-balancing mechanisms in Pseudomonas aeruginosa biofilms
$398,844Lars Dietrich · Columbia Univ New York Morningside · R01 · FY2018 · AI
Metabolic Control of Persistence in Individual Bacteria
$398,769Guillaume Lambert · Cornell University · R35 · FY2022 · GM
Oral Epithelial Cells, Candida and PMN Activation
$398,750Anna I Dongari-Bagtzoglou · University Of Connecticut Sch Of Med/Dnt · R01 · FY2017 · DE
MECHANISMS AND MACROMOLECULAR INTERACTIONS UNDERLYING CELLULAR RESPONSES TO STRESS SIGNALS
$398,750Alexandra M. Deaconescu · Brown University · R35 · FY2024 · GM